ReviewFrontiers in oncology2021

FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients.

Ye Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.